These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11858980)

  • 1. The EORTC soft tissue and bone sarcoma group. European Organisation for Research and Treatment of Cancer.
    Donato Di Paola E; Nielsen OS;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S138-41. PubMed ID: 11858980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the clinical trials activity of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research and Treatment of Cancer.
    Bramwell VH; Santoro A; Rouesse J; Mouridsen H; Steward W; Van Oosterom A; Somers R; Buesa J; Mulder J; Schutte J
    Semin Surg Oncol; 1988; 4(1):45-52. PubMed ID: 3281211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group.
    Iwamoto Y; Tanaka K
    Jpn J Clin Oncol; 2012 Jun; 42(6):467-70. PubMed ID: 22628611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pre- and postoperative chemotherapy in bone and soft tissue tumors].
    Höffken K
    Langenbecks Arch Chir; 1987; 372():311-4. PubMed ID: 3481009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and advancing systemic treatment options for soft tissue sarcomas.
    Harris SJ; Benson C; Jones RL
    Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of large and objectively measurable target lesions in EORTC phase II trials: impact on recruitment and response rate. EORTC Soft Tissue and Bone Sarcoma Group (STBSG).
    Van Glabbeke M; van Oosterom AT; Steward W; Verweij J; Mouridsen H
    Eur J Cancer; 1993; 29A(14):1943-7. PubMed ID: 8280486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft tissue and bone sarcomas.
    Santoro A; Bonadonna G
    Cancer Chemother Biol Response Modif; 1994; 15():620-7. PubMed ID: 7779603
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
    Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
    Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy and safety of apatinib combined with chemotherapy for osteosarcoma and soft tissue sarcoma with pulmonary metastasis].
    Li SL; Yang QK; Chen P; Zheng K; Wang W; Pei Y; Zhang XJ
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):309-314. PubMed ID: 31014058
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of chemotherapy for patients with bone and soft-tissue sarcomas.
    Wesolowski R; Budd GT
    Cleve Clin J Med; 2010 Mar; 77 Suppl 1():S23-6. PubMed ID: 20179184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
    Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
    Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
    Grignani G; D'Ambrosio L; Pignochino Y; Palmerini E; Zucchetti M; Boccone P; Aliberti S; Stacchiotti S; Bertulli R; Piana R; Miano S; Tolomeo F; Chiabotto G; Sangiolo D; Pisacane A; Dei Tos AP; Novara L; Bartolini A; Marchesi E; D'Incalci M; Bardelli A; Picci P; Ferrari S; Aglietta M
    Lancet Oncol; 2018 Oct; 19(10):1360-1371. PubMed ID: 30217671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Targets for Bone and Soft-Tissue Sarcomas.
    Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Tsuchiya H
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspective.
    Verweij J; van Oosterom AT; Somers R; Santoro A; Rouëssé J; Keizer J; Tursz T; Woll P; Steward W; Buesa J
    Ann Oncol; 1992 Apr; 3 Suppl 2():S75-80. PubMed ID: 1622874
    [No Abstract]   [Full Text] [Related]  

  • 17. Soft tissue and bone sarcomas.
    Santoro A; Bonadonna G
    Cancer Chemother Biol Response Modif; 1991; 12():603-13. PubMed ID: 1931458
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant chemotherapy in the treatment of sarcomas].
    Fayette J; Blay JY
    Bull Cancer; 2006 Mar; 93(3):257-61. PubMed ID: 16567312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies in surgical oncology: routine anthracycline-based adjuvant chemotherapy for stage III extremity soft tissue sarcoma.
    Bramwell VH
    Ann Surg Oncol; 2007 Apr; 14(4):1254-6. PubMed ID: 17103260
    [No Abstract]   [Full Text] [Related]  

  • 20. Current clinical trials for advanced osteosarcoma and soft tissue sarcoma.
    Sleijfer S; Gelderblom H
    Curr Opin Oncol; 2014 Jul; 26(4):434-9. PubMed ID: 24825018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.